Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Recurrent or Metastatic Head and Neck Cancer
NCT00199160Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Apr 2005
- Primary completion
- Jun 2010
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in head and neck cancer (HNC), sponsored by Institut Jules Bordet. Started Apr 2005; status: completed.
02
Drugs
sorafenib
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00199160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199160.